Article
Medicine, Research & Experimental
Wei Wang, Ruiying Sun, Lizhong Zeng, Yang Chen, Na Zhang, Shiguang Cao, Shanshan Deng, Xia Meng, Shuanying Yang
Summary: The study revealed that GALNT2 is highly expressed in LUAD and is associated with poor prognosis. GALNT2 promotes cancer cell proliferation and migration by activating the Notch/Hes1-PTEN-PI3K/Akt signaling axis, suggesting a potential new therapeutic target for LUAD.
Article
Medicine, Research & Experimental
Shan Zhu, Wenhui Jiao, Yanglu Xu, Lanjiao Hou, Hui Li, Jingrong Shao, Xiaoliang Zhang, Ran Wang, Dexin Kong
Summary: This study demonstrated the anti-proliferative and anti-metastatic activities of palmitic acid on human prostate cancer cells, potentially through targeting the PI3K/Akt pathway.
Article
Cell Biology
Chaoyang Zhou, Aijun Liang, Jianzhong Zhang, Jingxing Leng, Bin Xi, Bin Zhou, Yu Yang, Ronglan Zhu, Liangchen Zhong, Xingxing Jiang, Dengfeng Wan
Summary: ANTXR1 plays a crucial role in glioma tumorigenesis by regulating cell proliferation through activating the PI3K/AKT pathway, affecting cell growth, migration, apoptosis, and the cell cycle. Targeting ANTXR1 could serve as a molecular target in clinical therapeutics for gliomas.
Article
Biochemistry & Molecular Biology
Xufeng Wang, Xinyu Chang, Changyu He, Zhiyuan Fan, Zhenjia Yu, Beiqin Yu, Xiongyan Wu, Junyi Hou, Jianfang Li, Liping Su, Bingya Liu, Zhenggang Zhu
Summary: ATP5B is highly expressed in tumor tissues of GC and is positively correlated with age, tumor size, TNM stage, lymph node metastasis, and poor prognosis. Overexpression of ATP5B in GC cells increases cellular ATP content and promotes migration, invasion, and proliferation through the FAK/AKT/MMP2 pathway.
Article
Oncology
Lei Wei, Mika Pan, Qiulan Jiang, Beiquan Hu, Jianyi Zhao, Chun Zou, Liechun Chen, Chunhai Tang, Donghua Zou
Summary: This study found that Eukaryotic Initiation Factor 4A-3 (EIF4A3) is upregulated in glioblastoma (GBM) and high expression is associated with poor prognosis. Further experiments showed that EIF4A3 promotes proliferation and migration of GBM cells and interacts with the Notch1 signaling pathway. Therefore, EIF4A3 may serve as a potential prognostic factor for GBM.
Review
Nutrition & Dietetics
Eva Venusova, Adriana Kolesarova, Pavel Horky, Petr Slama
Summary: Punicalagin, a polyphenol found in pomegranate peel, has antioxidant, anti-inflammatory, anti-tumor activities, as well as hepatoprotective and anti-atherosclerotic effects.
Article
Oncology
Chuntao Li, Bo Chen, Junxia Zhang, Jingxuan Yang, Muzi Guo, Yu Ren, Zhijun Zhou, Kar-Ming Fung, Min Li, Liyang Zhang, Zhixiong Liu
Summary: SEM1 is highly expressed in gliomas and correlated with malignant features and poor prognosis. SEM1 plays a critical role in the proliferation, apoptosis, invasion, and migration of glioma cells through regulating the PI3K-Akt pathway. The SEM1 malignant regulatory network shows significant importance for the prognosis and treatment of gliomas.
Article
Cell Biology
Chunlei Guo, Shuang Li, Ang Liang, Mengchao Cui, Yunwei Lou, Hui Wang
Summary: PPA1 is highly expressed in breast cancer and correlated with poor survival in patients. Silencing PPA1 can inhibit breast cancer proliferation and metastasis. PPA1 serves as an activator of the PI3K/AKT/GSK3 beta/Slug-mediated breast cancer progression and is a potential therapeutic target for inhibiting tumor progression.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Medicine, Research & Experimental
Yu-Ge Zhu, Yun-Xia Lv, Chen-Yi Guo, Zhi-Min Xiao, Qun-Guang Jiang, Huang Kuang, Wen-Hua Zhang, Ping Hu
Summary: The study demonstrates that harmine significantly inhibits the proliferation and migration of U251-MG and U373-MG cells by suppressing the FAK/AKT signaling pathway. These results suggest that harmine could be a promising drug for glioblastoma therapy.
Article
Oncology
Jian Xu, Wei Zhang
Summary: This study revealed that EZR accelerates the progression of pancreatic cancer through the FAK/AKT signaling pathway, promoting proliferation and migration of PC cells.
CANCER CELL INTERNATIONAL
(2021)
Article
Biochemistry & Molecular Biology
Ming Wang, Wenyan Zhang, Yibo Liu, Zhigang Ma, Wei Xiang, Yuqi Wen, Dingkun Zhang, Yanling Li, Yeming Li, Tao Li, Ligang Chen, Jie Zhou
Summary: The study reveals that PDIA4 plays a critical role in promoting glioblastoma (GBM). Downregulation of PDIA4 inhibits proliferation and promotes apoptosis of GBM cells, potentially through suppressing protein phosphorylation levels of the PI3K/AKT/mTOR pathway.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2022)
Article
Oncology
Chaojian Xu, Ziyue Wang, Long Zhang, Yi Feng, Jia Lv, Zhuangzhuang Wu, Rong Yang, Taiyong Wu, Jian Li, Ruhao Zhou, Zhi Tian, Junjun Bai, Huadong Zhang, Yanping Lan, Zhi Lv
Summary: This study found that POSTN is highly expressed in osteosarcoma and is closely related to poor prognosis. Transfection of a POSTN-shRNA plasmid effectively inhibits the proliferation, invasion, and migration of osteosarcoma cells, indicating that POSTN may promote the progression and metastasis of osteosarcoma by activating the PI3K/Akt signaling pathway.
CANCER CELL INTERNATIONAL
(2022)
Article
Biochemistry & Molecular Biology
Feikai Lin, Jieru Zhou, Xiaoduan Li, Xipeng Wang
Summary: The study found that NOL4L is highly expressed in tumor tissues, especially in peritoneal metastatic tissues, and is associated with prognosis in ovarian cancer patients. Results showed that NOL4L promotes proliferation and metastasis of ovarian cancer cells.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2021)
Article
Oncology
Yixuan Wang, Qian Sun, Rongxin Geng, Hao Liu, Fan'en Yuan, Yang Xu, Yangzhi Qi, Hongxiang Jiang, Qianxue Chen, Baohui Liu
Summary: NICD is upregulated in human GBM tissues and promotes GBM proliferation via the Notch1 signaling pathway. NICD may serve as a potential diagnostic marker and therapeutic target for GBM treatment.
Article
Environmental Sciences
Wen Shi Yuan, Liu Yan Tong, Wei Bing Yan, Ma Jie Qiong, Chen Yan Yan
Summary: This study demonstrated that PDCD6 is overexpressed in hepatocellular carcinomas (HCCs) and promotes HCC cell proliferation, migration, and invasion through the AKT/GSK3 beta/beta-catenin signaling pathway. PDCD6 may serve as a potential target for HCC progression.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES
(2023)
Article
Oncology
Chunyu Zhang, Haitao Liu, Pengfei Xu, Yinqiu Tan, Yang Xu, Long Wang, Baohui Liu, Qianxue Chen, Daofeng Tian
Summary: In this study, we identified a five-lncRNA signature that can be used as a reliable tool for predicting the survival of glioma patients. The signature showed high predictive accuracy in different cohorts and was validated as an independent prognostic indicator.
Article
Pathology
Fanen Yuan, Qian Sun, Yang Xu, Huikai Zhang, Gang Deng, Jian Yang, Shenqi Zhang, Junhui Liu, Baohui Liu, Qianxue Chen
Summary: CircRNAs are increasingly recognized for their roles in glioblastoma (GBM), with hsa_circ_0072309 showing significant downregulation in GBM and inhibiting cell proliferation and invasion in this context. The interaction of hsa_circ_0072309 with HSP27 highlights its potential as a therapeutic target for comprehensive treatment of GBM.
PATHOLOGY RESEARCH AND PRACTICE
(2021)
Article
Oncology
Zhou Xu, Qianxue Chen, Xingnuo Zeng, Mingchang Li, Jianming Liao
Summary: The study revealed that lnc-NLC1-C is highly expressed in glioma cells, and its overexpression promotes cell proliferation, migration, and invasion while inhibiting apoptosis and autophagy. miR-383 binds to lnc-NLC1-C to regulate PRDX-3 expression, enhancing its oncogenic effect.
Article
Multidisciplinary Sciences
Qiang Cai, Zhiyang Li, Wenju Wang, Baowei Ji, Junhui Liu, Zhibiao Chen, Qianxue Chen, Shanping Mao
Summary: The study explores the feasibility and efficacy of a transcranial neuroendoscopic approach for hemorrhagic stroke (HS), showing that this method is highly effective in hematoma evacuation and safe for both primary and secondary HS.
SCIENTIFIC REPORTS
(2021)
Article
Pharmacology & Pharmacy
Yixuan Wang, Heng Shen, Qian Sun, Linyao Zhao, Hao Liu, Liguo Ye, Yang Xu, Jiayang Cai, Yuntao Li, Lun Gao, Yinqiu Tan, Baohui Liu, Qianxue Chen
Summary: GNE-477 significantly inhibits proliferation, migration, and invasion of GBM cells, induces apoptosis, and downregulates the AKT/mTOR pathway in vitro and in vivo, demonstrating significant antitumor effects on GBM.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Clinical Neurology
Ping Hu, Yang Xu, Yangfan Liu, Yuntao Li, Liguo Ye, Si Zhang, Xinyi Zhu, Yangzhi Qi, Huikai Zhang, Qian Sun, Yixuan Wang, Gang Deng, Qianxue Chen
Summary: This study developed a web-based dynamic nomogram to precisely evaluate the risk of poor outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). Independent prognostic factors such as neutrophil-to-lymphocyte ratio (NLR), World Federation of Neurosurgical Societies (WFNS) grade, and delayed cerebral ischemia (DCI) were identified. The developed nomogram demonstrated excellent discrimination and calibration capacities, providing a valuable tool for personalized treatment and better clinical decision-making.
FRONTIERS IN NEUROLOGY
(2021)
Correction
Behavioral Sciences
Pian Gong, Zhan Zhang, Changlin Zou, Qi Tian, Xuemei Chen, Michael Hong, Xi Liu, Qianxue Chen, Zhou Xu, Mingchang Li, Jian Wang
BEHAVIOURAL BRAIN RESEARCH
(2022)
Article
Neurosciences
Jing Cheng, Yan-Qin Fan, Hong-Xiang Jiang, Song-Feng Chen, Juan Chen, Xin-Yu Liao, Ying-Ying Zou, Hai-yang Lan, Yu Cui, Zhi-Biao Chen, Qian-Xue Chen, Qi Wan
Summary: The study found that tDCS treatment can reduce infarct volume after rat cerebral ischemia-reperfusion injury and improve the function of stroke animals. It was revealed that tDCS suppresses the upregulation of Cezanne, increases the level of SIRT6, and reduces DNA double-strand breaks, ultimately exerting neuroprotective effects in ischemic neurons.
EXPERIMENTAL NEUROLOGY
(2021)
Article
Cell Biology
Fanen Yuan, Qian Sun, Si Zhang, Liguo Ye, Yang Xu, Zhou Xu, Baohui Liu, Shenqi Zhang, Qianxue Chen
Summary: This study unveils novel molecular mechanisms of ferroptosis in glioma and identifies HSP27 as a negative regulator of ferroptosis and a potential target for the treatment of glioma.
Review
Immunology
Yang Xu, Huikai Zhang, Qian Sun, Rongxin Geng, Fanen Yuan, Baohui Liu, Qianxue Chen
Summary: Gliomas, the most common primary malignant tumor in adults' central nervous system, still lack breakthroughs in long-term treatment. Abnormalities in the immune regulatory mechanism in the tumor microenvironment are crucial for tumor cell survival, with alterations in amino acid metabolism impacting tumor cells and immune regulation mechanisms. Studying immune regulation of tryptophan metabolism in the tumor microenvironment of gliomas can help identify potential targets for treatment and enhance the efficacy of immunotherapy.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Cell Biology
Chunyu Zhang, Lirui Guo, Zhongzhou Su, Na Luo, Yinqiu Tan, Pengfei Xu, Liguo Ye, Shiao Tong, Haitao Liu, Xiaobin Li, Qianxue Chen, Daofeng Tian
Summary: Analyzing the tumor immune microenvironment of gliomas can predict the sensitivity to immunotherapy and patient prognosis. Higher TIMEscores were associated with increased tumor mutation burden and activation of immune-related biological processes, indicating potential sensitivity to immunotherapy. The TIMEscore was found to be a strong independent predictor of glioma prognosis and could guide adjuvant therapy decisions.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Neurosciences
Fanen Yuan, Si Zhang, Qian Sun, Liguo Ye, Yang Xu, Zhou Xu, Gang Deng, Shenqi Zhang, Baohui Liu, Qianxue Chen
Summary: The study demonstrated that hsa_circ_0072309 promotes autophagy through the p53 signaling pathway and enhances sensitivity to temozolomide in GBM. It may serve as a potential and promising target in designing treatment strategies for GBM.
CNS NEUROSCIENCE & THERAPEUTICS
(2022)
Article
Biochemistry & Molecular Biology
Fanen Yuan, Qian Sun, Si Zhang, Liguo Ye, Yang Xu, Gang Deng, Zhou Xu, Shenqi Zhang, Baohui Liu, Qianxue Chen
Summary: This study reveals a dual role of p62 in regulating ferroptosis in glioblastoma (GBM) depending on the status of p53. P62 overexpression promotes ferroptosis and inhibits SLC7A11 expression in p53 mutant GBM, while attenuates ferroptosis and promotes SLC7A11 expression in p53 wild-type GBM. The mutation status of p53 is a crucial factor in determining the therapeutic response to p62-mediated ferroptosis-targeted therapies in GBM.
CELL AND BIOSCIENCE
(2022)
Article
Neurosciences
Yonggang Zhang, Peng Ye, Hua Zhu, Lijuan Gu, Yuntao Li, Shi Feng, Zhi Zeng, Qianxue Chen, Benhong Zhou, Xiaoxing Xiong
Summary: This study investigated the potential effects of Neutral polysaccharide from Gastrodia elata (NPGE) on cerebral ischemia-reperfusion injury (CIRI) neuropathology. The results showed that NPGE treatment could alleviate neurological deficits, reduce infarct volume, and promote cell survival. Mechanistically, NPGE could regulate the expression of various signaling molecules, alleviating neuroinflammation and ferroptosis.
CNS NEUROSCIENCE & THERAPEUTICS
(2023)
Article
Oncology
Chunyu Zhang, Long Wang, Haitao Liu, Gang Deng, Pengfei Xu, Yinqiu Tan, Yang Xu, Baohui Liu, Qianxue Chen, Daofeng Tian
Summary: ADPRH is significantly upregulated in LGG and is associated with poor overall survival and progression-free survival. High expression of ADPRH is independently predictive of poor prognosis in LGG patients. GSEA analysis indicates involvement of ADPRH in multiple signaling pathways, and ADPRH expression correlates with tumor immune infiltrating cells.